Younes M - Search Results

1

Overexpression of Fas ligand (FasL) during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus.

Younes M, Schwartz MR, Finnie D, Younes A. Younes M, et al. Among authors: younes a. Hum Pathol. 1999 Nov;30(11):1309-13. doi: 10.1016/s0046-8177(99)90061-8. Hum Pathol. 1999. PMID: 10571510

2

Fas ligand expression in esophageal carcinomas and their lymph node metastases.

Younes M, Schwartz MR, Ertan A, Finnie D, Younes A. Younes M, et al. Among authors: younes a. Cancer. 2000 Feb 1;88(3):524-8. Cancer. 2000. PMID: 10649242

3

Decreased expression of Fas (CD95/APO1) associated with goblet cell metaplasia in Barrett's esophagus.

Younes M, Lechago J, Ertan A, Finnie D, Younes A. Younes M, et al. Among authors: younes a. Hum Pathol. 2000 Apr;31(4):434-8. doi: 10.1053/hp.2000.6715. Hum Pathol. 2000. PMID: 10821489

4

Estrogen receptor beta expression in invasive breast cancer.

Mann S, Laucirica R, Carlson N, Younes PS, Ali N, Younes A, Li Y, Younes M. Mann S, et al. Among authors: younes a, younes ps, younes m. Hum Pathol. 2001 Jan;32(1):113-8. doi: 10.1053/hupa.2001.21506. Hum Pathol. 2001. PMID: 11172304

5

Estrogen receptor beta is expressed in human colorectal adenocarcinoma.

Witte D, Chirala M, Younes A, Li Y, Younes M. Witte D, et al. Among authors: younes a, younes m. Hum Pathol. 2001 Sep;32(9):940-4. doi: 10.1053/hupa.2001.27117. Hum Pathol. 2001. PMID: 11567223

6

Receptor activator of nuclear factor kappaB (RANK) is expressed as a late event during malignant progression in Barrett's metaplasia.

Yorke R, Younes A, Chirala M, Younes M. Yorke R, et al. Among authors: younes a, younes m. Eur J Cancer. 2003 Sep;39(14):2099-102. doi: 10.1016/s0959-8049(03)00434-9. Eur J Cancer. 2003. PMID: 12957466

7

Optimized cyclin D1 immunoperoxidase staining in mantle cell lymphoma.

Korin HW, Schwartz MR, Chirala M, Younes M. Korin HW, et al. Among authors: younes m. Appl Immunohistochem Mol Morphol. 2000 Mar;8(1):57-60. doi: 10.1097/00129039-200003000-00009. Appl Immunohistochem Mol Morphol. 2000. PMID: 10937050

8

Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.

Younes M, Pathak M, Finnie D, Sifers RN, Liu Y, Schwartz MR. Younes M, et al. Anticancer Res. 2000 Sep-Oct;20(5C):3775-9. Anticancer Res. 2000. PMID: 11268453

9

Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma.

Younes M, Georgakis GV, Rahmani M, Beer D, Younes A. Younes M, et al. Among authors: younes a. Eur J Cancer. 2006 Mar;42(4):542-7. doi: 10.1016/j.ejca.2005.11.013. Epub 2006 Jan 19. Eur J Cancer. 2006. PMID: 16426839

10

Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival.

Baer S, Casaubon L, Schwartz MR, Marcogliese A, Younes M. Baer S, et al. Among authors: younes m. Laryngoscope. 2002 Feb;112(2):393-6. doi: 10.1097/00005537-200202000-00034. Laryngoscope. 2002. PMID: 11889403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

892 results

Search Page

Filters